Abdul Rasheed Mohammed

Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease

Ramakrishna Nirogi, Abdul Rasheed Mohammed, Anil Shinde et al. · European Journal of Medicinal Chemistry · 2015 · 57 citations · Full text

Medicinal Chemistry, Medicine, Pharmacological Agent +6

Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1<i>H</i>-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT₆) Receptor Antagonist for Potential Treatment of Alzheimer’s Disease

Ramakrishna Nirogi, Anil Shinde, Rama Sastry Kambhampati et al. · Journal of Medicinal Chemistry · 2017 · 45 citations · Full text

Synthesis, Structure–Activity Relationships, and Preclinical Evaluation of Heteroaromatic Amides and 1,3,4-Oxadiazole Derivatives as 5-HT₄ Receptor Partial Agonists

Ramakrishna Nirogi, Abdul Rasheed Mohammed, Anil Shinde et al. · Journal of Medicinal Chemistry · 2018 · 29 citations · Full text

Discovery and Development of 3-(6-Chloropyridine-3-yloxymethyl)-2-azabicyclo[3.1.0]hexane Hydrochloride (SUVN-911): A Novel, Potent, Selective, and Orally Active Neuronal Nicotinic Acetylcholine α4β2 Receptor Antagonist for the Treatment of Depression

Ramakrishna Nirogi, Abdul Rasheed Mohammed, Anil Shinde et al. · Journal of Medicinal Chemistry · 2020 · 24 citations · Full text

Discovery and Development of <i>N</i>-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine H₃ Receptor Inverse Agonist with Robust Wake-Promoting Activity

Ramakrishna Nirogi, Anil Shinde, Abdul Rasheed Mohammed et al. · Journal of Medicinal Chemistry · 2019 · 20 citations · Full text